| ICD-9-CM: |
| 250 - | Diabetes Mellitus |
| 250.01 - | Diabetes Mellitus Type I |
| 250.03 - | Diabetes Mellitus without Mention of Complication; Type I [Juvenile Type], Uncontrolled |
| 250.1 - | Diabetes with Ketoacidosis (Diabetic Acidosis) |
| 250.11 - | Diabetes with Ketoacidosis; Diabetic: Acidosis without Mention of Coma, Ketosis without Mention of Coma; Type I [Juvenile Type], not Stated as Uncontrolled |
| 250.13 - | Diabetes with Ketoacidosis; Diabetic: Acidosis without Mention of Coma, Ketosis without Mention of Coma; Type I [Juvenile Type], Uncontrolled |
| 250.2 - | Diabetes with Hyperosmolarity; Hyperosmolar (Nonketotic) Coma |
| 250.21 - | Diabetes with Hyperosmolarity; Hyperosmolar (Nonketotic) Coma; Type I [Juvenile Type], Not Stated as Uncontrolled |
| 250.23 - | Diabetes with Hyperosmolarity; Hyperosmolar (Nonketotic) Coma; Type I [Juvenile Type], Uncontrolled |
| 250.3 - | Diabetes with Other Coma |
| 250.31 - | Diabetes with Other Coma; Diabetic Coma (with Ketoacidosis), Diabetic Hypoglycemic Coma, Insulin Coma NOS; Type I [Juvenile Type], Not Stated as Uncontrolled |
| 250.33 - | Diabetes with Other Coma; Diabetic Coma (with Ketoacidosis), Diabetic Hypoglycemic Coma, Insulin Coma NOS; Type I [Juvenile Type], Uncontrolled |
| 250.4 - | Diabetic Glomerulosclerosis |
| 250.41 - | Diabetes with Renal Manifestations; Type I [Juvenile Type], not Stated as Uncontrolled |
| 250.43 - | Diabetes with Renal Manifestations; Type I [Juvenile Type], Uncontrolled |
| 250.5 - | Diabetes with Ophthalmic Manifestations |
| 250.51 - | Diabetes with Ophthalmic Manifestations; Type I [Juvenile Type], not Stated as Uncontrolled |
| 250.53 - | Diabetes with Ophthalmic Manifestations; Type I [Juvenile Type], Uncontrolled |
| 250.6 - | Diabetes with Neurological Manifestations |
| 250.61 - | Diabetes with Neurological Manifestations; Type I [Juvenile Type], not Stated as Uncontrolled |
| 250.63 - | Diabetes with Neurological Manifestations; Type I [Juvenile Type], Uncontrolled |
| 250.7 - | Diabetic Gangrene |
| 250.71 - | Diabetes with Peripheral Circulatory Disorders; Type I [Juvenile Type], Not Stated as Uncontrolled |
| 250.73 - | Diabetes with Peripheral Circulatory Disorders; Type I [Juvenile Type], Uncontrolled |
| 250.8 - | Diabetes with Other Specified Manifestations |
| 250.81 - | Type I (Insulin Dependent Type) Diabetes Mellitus with Other Specified Manifestations, Not Stated as Uncontrolled |
| 250.83 - | Type I (Insulin Dependent Type) Diabetes Mellitus with Other Specified Manifestations, Uncontrolled |
| 250.9 - | Diabetes with Unspecified Complications |
| 250.91 - | Diabetes with Unspecified Complications; Type I [Juvenile Type], not Stated as Uncontrolled |
| 250.93 - | Diabetes with Unspecified Complications; Type I [Juvenile Type], Uncontrolled |
| Diabetes mellitus (diabetes) is a chronic disorder characterized by abnormally high levels of a simple sugar (glucose) in the blood (hyperglycemia). Type I diabetes (or insulin-dependent diabetes) results when the body fails to produce enough of the hormone insulin. Individuals with type I diabetes require daily doses of insulin to stay alive.
Insulin is a hormone produced in an organ near the stomach called the pancreas; it is required by the body to convert food into energy. In individuals with type I diabetes, the pancreas does not produce enough insulin because the insulin-producing cells have been destroyed by the body's immune system. Without insulin, glucose cannot be transported from the blood to the body's cells, so it accumulates in the blood, resulting in hyperglycemia. When the unused glucose in the blood is excreted in the urine (glycosuria), it causes the kidney to release more water (osmotic diuresis), which is then excreted in large quantities of urine (polyuria). Polyuria leads to dehydration and activates the thirst mechanism resulting in the consumption of large quantities of fluid (polydipsia).Risk: Type I diabetes is usually diagnosed during childhood or adolescence, although adults can develop this disease. Approximately 12 million non-Hispanic whites had type I diabetes in 2002. However, Native Americans and Alaska Natives are about 2.3 times as likely and non-Hispanic blacks and Latinos are about 1.5 times as likely as to have diabetes as non-Hispanic whites of similar age ("National Diabetes Statistics").
Although type I diabetes tends to run in families, siblings of individuals with type I diabetes may not always get diabetes. Even though an identical twin of an individual with this disease has close to a 50% chance of developing type I diabetes, it is believed that some environmental exposure is also responsible for the development of the disease.
Individuals who have other autoimmune diseases such as Graves' disease, Hashimoto's thyroiditis, and Addison's disease are also more susceptible to type I diabetes. Incidence and Prevalence: Approximately 1.3 million people over the age of 20 are diagnosed with type I diabetes mellitus each year ("National Diabetes Statistics"). However, it is estimated that millions have undiagnosed diabetes. |
Source: Medical Disability Advisor
| History: Symptoms may develop suddenly or gradually over days to weeks and vary widely from person to person. Common symptoms include excessive thirst and water intake (polydipsia), excessive urination (polyuria), weight loss despite normal or increased food intake, fatigue, headaches, muscle wasting, muscle cramps, vision changes, visible weight loss from loss of body fluids, anxiety, nausea, vomiting, and diarrhea and/or constipation. Excessive food intake (polyphagia) is a classic but uncommon symptom of this disease; loss of appetite (anorexia) is more commonly reported. Physical exam: Physical findings vary with the suddenness and severity of onset of the disease. Some findings include signs of dehydration such as low blood pressure (hypotension), weak rapid pulse, dry mucous membranes (especially the mouth), and blurred vision. Breathing may be deep and rapid. Individuals with this disease tend to be thin, usually with little body fat at the time of diagnosis. However, heavy individuals can also have type I diabetes. A fruity odor to the breath may indicate ketoacidosis, a common complication of this disease. Tests: A urine dipstick will measure glucose and ketones in the urine (both will be positive). A random blood glucose level and fasting blood glucose level will be elevated. A 2-hour-after-eating (postprandial) blood glucose level will also be elevated. Other blood tests will reflect dehydration and the effects on other blood chemicals (serum electrolytes). Further testing is usually not needed to make the diagnosis, although blood typing for human leukocyte antigen (HLA)-DR3 and HLA-DR4, considered to be specific markers for susceptibility to type I diabetes mellitus, may be helpful. Autoimmune association may also be determined by baseline thyroid function tests (for Hashimoto's thyroiditis), and measurement of morning cortisol levels (for Addison's disease) and autoantibodies (for celiac disease). In addition, the presence of antibodies to pancreatic islet cells (glutamic acid decarboxylase antibodies, or GAD antibodies) is a marker of islet cell destruction, which is typical to type I diabetes mellitus.
Periodic testing of glycosylated hemoglobin (Hb), or the HbA1c test, can give an estimate of plasma glucose control over the preceding 1 to 3 months, and may help the physician adjust the individual's insulin requirements. The insulin C-peptide test may be performed to determine if any insulin is still being produced by the body, which can guide treatment using replacement insulin. |
Source: Medical Disability Advisor
| Type I diabetes is treated with injections of insulin to maintain a stable blood glucose level. The type of insulin is based on the body's response to the insulin; the amount and frequency of dosage is determined by the blood glucose level. The individual learns how to monitor blood glucose levels, and the physician sets guidelines to regulate the insulin dosages based on the blood glucose level reading. The individual also learns how to administer insulin, and the importance of complying with treatment is emphasized. Insulin injections may be administered by vial-and-syringe methods, smaller convenient pen devices, or continuous subcutaneous insulin pump. There is also newer 24-hour insulin available that need only be injected once in a 24 hour period. Diet, exercise, and stress reduction techniques also assist in regulating blood glucose levels. Included in education is the importance of daily foot care and the need for early treatment of even minor scratches or wounds.
In some individuals, insulin injections, diet, exercise, and stress reduction might not be sufficient to control their glucose levels. For these individuals, an insulin pump should be considered. The insulin pump is a mechanical device, about the size of a pager, which administers insulin according to the schedule prescribed by the physician; it is programmed by the individual. The pump delivers a small amount of insulin continuously throughout the day, providing a base level much like the pancreas would do if it were working properly. In addition, the pump is programmed to deliver larger amounts of insulin (bolus doses) before each meal, according to the type and size of meal eaten. The insulin pump is not automatic; it does not monitor glucose levels or calculate the necessary amount of insulin. It only delivers the amount of insulin programmed by the individual, at the scheduled times. Therefore, the individual must continue to monitor blood sugar frequently throughout the day, at least 4 to 6 times for optimal control. This schedule applies to all individuals with Type I diabetes mellitus, regardless of how the insulin is given. However, an implantable pump is on the research horizon which may integrate glucose sensing meters into a feedback-loop system, allowing insulin to be delivered according to monitored blood glucose levels without the individual needing to calculate and program the device. Other newer promising methods of insulin delivery include inhalable insulin, currently awaiting Food and Drug Administration (FDA) approval.
Physical exams at least twice a year (preferably 4 to 5 times a year) are needed to evaluate the stability of disease, as well as to permit early treatment for any complications or progressive symptoms. A blood test (glycosylated hemoglobin) that measures the amount of glucose bound to a protein called hemoglobin (found in red blood cells) monitors blood glucose levels over the preceding 60 to 90 days (hemoglobin A1c, or HbA1c test). This test is useful to the physician and individual in assessing glucose control and provides information to guide the physician in adjusting the individual's insulin requirements. Individuals will need at least annual dilated retinal exams. The individual and family members should be educated in symptoms of hyperglycemia, acidosis, and hypoglycemia.
For certain individuals a pancreatic transplant may be considered, although transplantation of pancreatic islet cells may be an option in the future when supported by newer immunosuppressants. |
Source: Medical Disability Advisor
| The outcome depends on individual compliance with treatment and the development and progression of complications. With blood glucose control and attentive self-care, the outcome is good. Individuals with type I diabetes mellitus have a slightly shorter life expectancy than healthy individuals. |
Source: Medical Disability Advisor
| Complications of type I diabetes mellitus can occur even when the disease is effectively controlled. They include infections, damage to the nervous system (diabetic neuropathy), kidney disease (diabetic glomerulosclerosis), visual problems from diseased blood vessels in the eye (diabetic retinopathy, glaucoma), hardening of the arteries (atherosclerosis), excessive fat in the blood (hyperlipidemia), foot problems, decreased blood pH (ketoacidosis), excessive weight gain, coma, and death. Impotence is common among men with diabetes.
Diabetes increases the risk of developing high blood pressure (hypertension) and elevated cholesterol levels (hypercholesterolemia), which may lead to an increased risk of heart attack and stroke.
Women attempting to conceive should closely monitor and control blood glucose levels prior to conception to reduce the risks of birth defects in the developing embryo. |
Source: Medical Disability Advisor
| Work accommodations may include a flexible schedule to allow for sick days and frequent breaks for small meals or insulin injections; for some a reduced work week may be necessary. A private place, with facilities for hand washing and disposal of glucose testing strips and syringes, may be needed to allow for monitoring glucose levels and administering insulin. Limitations may be placed on continuous physical exertion, working in extreme temperatures or moist areas, working at unprotected heights, and working in isolated areas alone. As the disease progresses, work requiring visual acuity, fine dexterity, prolonged walking, or heavy labor may need to be limited. |
Source: Medical Disability Advisor
| If an individual fails to recover within the expected maximum duration period, the reader may wish to consider the following questions to better understand the specifics of an individual's medical case. Regarding diagnosis:
- Does individual have a family history of diabetes?
-
Does individual complain of polydipsia, polyuria, weight loss despite normal or increased food intake, fatigue, headaches, muscle wasting, muscle cramps, vision changes, visible weight loss from loss of body fluids, anxiety, nausea, vomiting, diarrhea, and/or constipation? Does individual have polyphagia or anorexia?
-
Did physical exam reveal hypotension, weak rapid pulse, or dry mucous membranes (especially the mouth)? Was breathing deep and rapid?
-
At the time of diagnosis, was individual thin with little or no body fat?
-
Does individual's breath have a fruity odor to it?
-
Was urine testing done for glucose and ketones? Comprehensive blood sugar testing? Complete blood chemistry testing?
-
Were conditions with similar symptoms ruled out?
Regarding treatment:
- Were injections of insulin given?
-
Does individual monitor blood sugar?
-
Has individual received training regarding diet, exercise, and stress reduction? Daily foot care? Early treatment of minor scratches or wounds?
-
Was individual compliant with treatment regime?
-
Is individual a candidate for an insulin pump?
Regarding prognosis:
- Can individual's employer accommodate any necessary restrictions?
-
Does individual have any conditions that may affect ability to recover?
-
Have any complications developed, such as infections, diabetic neuropathy, diabetic glomerulosclerosis, diabetic retinopathy, glaucoma, atherosclerosis, hyperlipidemia, foot problems, ketoacidosis, excessive weight gain, or coma?
-
Is individual impotent? Does individual have psychological problems related to dealing with a chronic disease?
|
Source: Medical Disability Advisor
| "National Diabetes Statistics." National Diabetes Information Clearinghouse (NDIC). Apr. 2004. National Institutes of Health (NIH). 16 Dec. 2004 <http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm#7>. |
Source: Medical Disability Advisor
| Feedback |
| Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must
include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment.
If you are seeking medical advice, please contact your physician. Thank you! |
Send this comment to:
Sales
Customer Support
Content Development
|
|
| |
|
|
|
|
|
This publication is designed to provide accurate and authoritative information in
regard to the subject matter covered. It is published with the understanding that
the author, editors, and publisher are not engaged in rendering medical, legal,
accounting or other professional service. If medical, legal, or other expert assistance
is required, the service of a competent professional should be sought. We are unable to respond to requests for advice.
Any Sales inquiries should include an email address or other means of
communication.
|